Johnson & Johnson

162.24+1.85+1.15%Vol 8.80M1Y Perf 8.44%
Apr 16th, 2021 16:00 DELAYED
BID162.12 ASK162.22
Open161.34 Previous Close160.39
Pre-Market- After-Market162.22
 - -  -0.02 -0.01%
Target Price
183.08 
Analyst Rating
Moderate Buy 1.56
Potential %
12.85 
Finscreener Ranking
★★     45.81
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★     47.73
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★     59.05
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
★★+     44.70
Market Cap427.13B 
Earnings Rating
Buy
Price Range Ratio 52W %
71.48 
Earnings Date
20th Apr 2021

Today's Price Range

160.56162.51

52W Range

133.65173.65

5 Year PE Ratio Range

17.20310.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.61%
1 Month
0.91%
3 Months
1.21%
6 Months
10.31%
1 Year
8.44%
3 Years
24.28%
5 Years
49.29%
10 Years
211.11%

TickerPriceChg.Chg.%
JNJ162.241.85001.15
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.20
0.34
0.56
83.10
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
65.60
20.20
29.00
20.20
14.08
RevenueValueIndustryS&P 500US Markets
61.89B
23.51
1.52
3.71
DividendsValueIndustryS&P 500US Markets
2.50
4.04
6.20
6.14
Payout ratio61.00
Earnings HistoryEstimateReportedSurprise %
Q04 20201.811.862.76
Q03 20201.992.2010.55
Q02 20201.501.6711.33
Q01 20202.032.3013.30
Q04 20191.861.881.08
Q03 20192.002.126.00
Q02 20192.422.586.61
Q01 20192.032.103.45
Earnings Per EndEstimateRevision %Trend
3/2021 QR2.314.52Positive
6/2021 QR2.339.91Positive
12/2021 FY9.486.64Positive
12/2022 FY10.224.93Positive
Next Report Date20th Apr 2021
Estimated EPS Next Report2.31
Estimates Count7
EPS Growth Next 5 Years %7.70
Volume Overview
Volume8.80M
Shares Outstanding2.63B
Trades Count88.71K
Dollar Volume2.20B
Avg. Volume8.20M
Avg. Weekly Volume9.06M
Avg. Monthly Volume7.85M
Avg. Quarterly Volume8.17M

Johnson & Johnson (NYSE: JNJ) stock closed at 162.24 per share at the end of the most recent trading day (a 1.15% change compared to the prior day closing price) with a volume of 9.05M shares and market capitalization of 427.13B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 136400 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is 8.44%, while year-to-date (YTD) performance is 3.09%. JNJ stock has a five-year performance of 49.29%. Its 52-week range is between 133.65 and 173.65, which gives JNJ stock a 52-week price range ratio of 71.48%

Johnson & Johnson currently has a PE ratio of 29.60, a price-to-book (PB) ratio of 6.78, a price-to-sale (PS) ratio of 6.88, a price to cashflow ratio of 18.50, a PEG ratio of 2.32, a ROA of 8.54%, a ROC of 17.93% and a ROE of 23.11%. The company’s profit margin is 14.08%, its EBITDA margin is 29.00%, and its revenue ttm is $61.89 Billion , which makes it $23.51 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.31 for the next earnings report. Johnson & Johnson’s next earnings report date is 20th Apr 2021.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (1.56), with a target price of $183.08, which is +12.85% compared to the current price. The earnings rating for Johnson & Johnson stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.50% with a dividend per share of $4.04 and a payout ratio of 61.00%.

Johnson & Johnson has a Buy technical analysis rating based on Technical Indicators (ADX : 9.51, ATR14 : 3.49, CCI20 : -14.32, Chaikin Money Flow : 0.17, MACD : -0.53, Money Flow Index : 50.24, ROC : -1.68, RSI : 48.43, STOCH (14,3) : 54.38, STOCH RSI : 1.00, UO : 55.32, Williams %R : -45.62), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $0), Ashley McEvoy (Option Excercise at a value of $0), Ashley McEvoy (Sold 29 000 shares of value $4 276 630 ), Jennifer L. Taubert (Option Excercise at a value of $0), Joaquin Duato (Option Excercise at a value of $0), Joseph J. Wolk (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $1 027 323), Kathryn E. Wengel (Sold 16 115 shares of value $2 473 937 ), Michael E. Sneed (Option Excercise at a value of $6 799 952), Michael E. Sneed (Sold 109 324 shares of value $16 718 918 ), Michael H. Ullmann (Option Excercise at a value of $0), Paulus Stoffels (Option Excercise at a value of $0), Peter M. Fasolo (Option Excercise at a value of $0), Robert J. Decker (Option Excercise at a value of $0), Thibaut Mongon (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (68.75 %)
11 (68.75 %)
10 (66.67 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (6.67 %)
Hold
4 (25.00 %)
4 (25.00 %)
4 (26.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Moderate Buy
1.56
Moderate Buy
1.60

Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

CEO: Alex Gorsky

Telephone: +1 732 524-0400

Address: One Johnson and Johnson Plaza, New Brunswick 08933, NJ, US

Number of employees: 136 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

55%45%

Bearish Bullish

53%47%

Bearish Bullish

52%48%

News

Stocktwits